Apr 11
Dr. Nathan Treff presenting at EXPERMED International Conference
Location: Turkish Republic of Northern Cyprus

Apr 15
Dr. Nathan Treff presenting at Preimplantation Genetic Diagnosis International Society (PGDIS)
Location: Geneva, Switzeland

Jun 23
Dr. Nathan Treff presenting at European Society of Human Reproduction and Embryology (ESHRE)
Location: Vienna, Austria
Title: “Chromosomal mosaicism in human embryos: Incidence, prevalence, diagnostic possibilities and clinical management in PGT-A cycles”

Nov 23
Dr. Nathan Treff presenting at 26th World Congress on Controversies in Obstetrics, Gynecology & Infertility, London
Location: London
Title: "Mitochondrial DNA (mtDNA) can serve as a biomarker of pre-implantation embryo viability."

Nov 18
Dr. Nathan Treff presenting at Rutgers Genetic Course Lecture
Location: New Brunswick, NJ
Title: “Preimplantation Genetic Testing”

Nov 15
Dr. Treff presenting at Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference, New York
Location: New York
Title: “Explaining the purpose of PGS/PGT-A”
Nov 02
Dr. Nathan Treff presenting at The 5th World Congress on Controversies in Preconceptional, Preimplantation, and Prenatal Diagnosis (CoGEN)
Location: Paris
Title: “Mosaicism in PGT-A – Is it a red herring?
Oct 10
Validation of simultaneous preimplantation genetic testing (PGT) for aneuploidy, monogenic, and polygenic disorders.
Location: Denver
Dr. Nathan Treff presenting at American Society for Reproductive Medicine (ASRM) Denver

Our primary objective as a company is to make available, for the first time, methods to predict polygenic disease risk in preimplantation embryos. We have pioneered the development of polygenic disease risk prediction from genome wide analyses, using millions of genomes from large public repositories, you can read about them in our news section. We will be presenting on methods for preimplantation genetic testing for polygenic disease risk (PGT-P) for risk of Type 1 and Type 2 Diabetes, Dwarfism, Hypothyroidism, Mental Disability, Heart Disease factors like Atrial Fibrillation and Coronary Artery Disease, Inflammatory Bowel Disease, and Breast Cancer Predisposition.


Sep 29
Dr. Nathan Treff presenting at Origins of Aneuploidy Meeting Toronto
Location: Toronto
Presenting on the Origin of Aneuploidy in Meiotic Cell Division

This event has a Google Hangouts video call.


Jun 19
Dr. Nathan Treff presenting at The 7th Annual Future Congress 2018, Wolfsburg, Germany
Location: Wolfsburg, Germany
Title: “Preimplantation Genetic Testing: preventing and curing heritable genetic disease”
Jun 07
Dr Nathan Treff presenting at The 2018 Midwest Reproductive Symposium International in Chicago
Location: Chicago
Title: “Speaker Panel: The floor plan of PGS in your practice: revenues, risk management, legal and ethical issues,” “Mosaicism is a Gimmick,” “Sharing the results of PGS of mosaicism: key points to consider”
Jun 02
Dr Nathan Treff presenting at OvaTools ART Institute 2nd Annual Symposium in Fort Lauderdale
Location: Fort Lauderdale
Title: “Monogenic disease and trait analysis testing platforms”
May 28
Dr Nathan Treff presenting at International Summit on Assisted Reproduction and Genetics
Location: Israel, Tel Aviv
Title: “From Expanded Carrier Screening to PGD”
May 18
Dr Nathan Treff presenting at Alpha 12th Biennial Conference
Location: Reykjavik
Title: “Aetiology of mosaicism and which to transfer”
May 16
Dr Nathan Treff attending AAB HCLD Exam Orlando *passed
Location: Orlando
Apr 06
Dr. Nathan Treffe presenting at Evidence based assisted reproductive technology 2nd annual conference in Barcelona
Location: Barcelona
Title: “What should we do with mosaic embryos”
© Genomic Prediction, 2019